Stereotaxis, Inc. (STXS) Dividend History

Stereotaxis, Inc. is a medical technology company that specializes in the development and application of robotic systems for minimally invasive cardiac procedures. Founded in 2001, the company focuses on using innovative robotics and imaging technologies to improve the precision, safety, and outcomes of electrophysiology and cardiac surgery interventions. Its flagship product, the Niobe robotic magnetic navigation system, aids physicians in navigating catheters within the heart with enhanced accuracy.

Dividend History

Stereotaxis, Inc. currently does not pay dividends

Company News

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Stereotaxis, a leader in surgical robotics, will release its Q1 2025 financial results on May 12, 2025 and host a conference call to discuss the company's performance and developments.

GlobeNewswire Inc.
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc.

The global magnetic ablation catheters market is expected to grow significantly, reaching $1.1 billion by 2035, driven by advancements in technology and the rising prevalence of cardiovascular diseases. Key factors driving growth include the increasing adoption of minimally invasive procedures and continued investment in healthcare infrastructure and R&D.

GlobeNewswire Inc.

Featured Companies: ABT BSX JNJ LIVN MDT
Medical Robots Market Report: Technological Advancements in Medical Industry and Growth of AI to Boosts the Demand | Future Market Insights, Inc.

The global medical robot market is set to witness significant growth, driven by technological advancements, increased demand for minimally invasive surgeries, and the rising adoption of robotics in healthcare. The market is expected to grow from $11.5 billion in 2024 to $38.7 billion by 2034, at a CAGR of 12.9%.

GlobeNewswire Inc.

Featured Companies: IRBT ISRG MDT
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

The most advanced robotic cardiac ablation lab opens at Penn Presbyterian Medical Center.

GlobeNewswire Inc.
Stereotaxis (STXS) Gets CE Recertification for Approved Products

Stereotaxis' (STXS) receives updated EU Quality Management System Certificate, which demonstrates compliance with MDR.

Zacks Investment Research

Featured Companies: HIMS MEDP RMD

Dividend data last updated 06/07/2025 22:06:43 UTC